• 26Nov

    The Online retail industry has always been a difficult sector for new brands to break into as the giant Amazon brand has maintained a huge 20 percent share of the fashion market. One brand aking a quick and lasting impression on the Online retail industry is Fabletics, the subscription-based retailer offering a range of activewear backed by the actress Kate Hudson. Fabletics has developed a technology-based system for creating a membership which is constantly expanding from the initial stages where a lifestyle quiz is completed to start the process of finding the best clothing available and should be completed by anybody wanting to join the company.

    Fabletics has been looking for new ways of exploring the showrooming issues which have been plaguing the retail industry for many years and turning it to their advantage. Over the course of the life of Fabletics which was established in 2013; unlike many of its competitors who began life on the Internet, the brand has grown to include a number of physical locations from where the brand is using a “reverse showrooming” technique to bring more business into the company. The physical locations allow both members and non-members to enter stores and discover the latest collections from the brand which can be purchased or ordered from the brand as part of the membership brand.

    One of the major reasons for the success of the Fabletics brand has been its close link to founding partner, Kate Hudson. The actress who shot to fame in “Almost Famous” has been involved with the brand since the TechStyle Group made the decision to create an activewear brand with an ambassador who reflected the healthy, active lifestyle the brand is promoting. Kate Hudson is often pictured on the pages of her social media accounts wearing the clothing produced by Fabletics and has become one of the main marketing tools for the company in its bid to overcome the dominance of Amazon.

    The TechStyle Group has estimated the value of Fabletics to have already reached $250 million but Kate Hudson still states she is an actress first and business leader second. Despite her claims, Kate Hudson has become involved with almost every aspect of the Fabletics brand from budgeting to the development of a new customer service department and policy to provide the best experience for all customers.


  • 19Sep

    Accomplished Seattle Genetics CEO, co-founder, and board chairman, Clay Siegall, Ph.D., was appointed to the board of Mirna Therapeutics in January 2013. Siegall’s appointment allowed him to serve the private biotechnology company as its outside director.

    Seattle Genetics Co-Founder Appointed to Board of Directors for Mirna Therapeutics Inc.

    Mirna Therapeutics is based in Austin, Texas. The company was founded in 2007 and currently focuses on developing microRNA in therapeutics. The company’s main focus is in cancer research, a field that Siegall has a wealth of knowledge in. Paul Lammers, the CEO of Mirna Therapeutics, expressed his excitement at the appointment and confirmation of Clay Siegall into their Board of Directors.

    Lammers said that he expected Siegall to be invaluable in guiding the company through its research and advancements in the development of microRNA therapeutics. He acknowledged that the hiring decision was an excellent one.

    Clay Siegall, Ph.D.

    Clay Siegall helped to co-find and establish Seattle Genetics. Today, he serves as company CEO and the Chairman of its Board of Directors. Under the direction and management of Siegall, the company successfully created working antibody-based therapies that are useful for cancer patients who are not adequately taken care of – in terms of their medical needs. Additionally, Siegall holds 15 patents and is a successfully published author with over 70 published works.

    Siegall attended University of Maryland and graduated four years later with a Bachelor of Science Degree in Zoology. He later enrolled at George Washington University for his Ph.D. in Genetics. After graduating, he secured employment at the National Cancer Institute, National Institutes of Health. He later worked at Bristol-Myers Squibb Pharmaceutical Research Institute. He left the company to start Seattle Genetics back in 1998.

    Seattle Genetics

    Today, Seattle Genetics is one of the country’s leading biotechnology companies that specializes in the development of preclinical and clinical products. Since its inception, the company has commercialized innovative and effective antibody-drug conjugate (ADC) that is useful for cancer treatment.

    The company has curved out a name for itself in the industry as a rigorous research facility dedicated to the development and improvement of scientific innovations and useful drug development practices relevant to medicine. The company’s headquarters are located in Bothell Washington. It is traded on the Nasdaq Stock Market.



Single Links